PharmaCyte Biotech, Inc.

NASDAQ:PMCB

1.86 (USD) • At close November 12, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Omzet 000000000000.0120.0670.1260.2630.6531.191.170.5370.0860.00200
Kosten van de omzet 000000000000.010.0190.0320.2290.4270.2660.17100.0410.00100
Brutowinst 000000000000.0030.0470.0940.0340.2260.9240.9990.5370.0450.00200
Brutowinstmarge 000000000000.2090.7090.7450.130.3460.7760.85410.5210.67300
Onderzoek- en ontwikkelingskosten 0.4070.4690.6910.9160.3010.461.9981.1821.4073.4770000.0090.4920.4740.4130.1340.1191.1081.40900
Algemene en administratieve kosten 2.1175.9873.7012.7073.5253.6414.9843.264.6669.98818.1071.581.9850.4621.2395.2006.5590000
Verkoop- en marketingkosten 1.322000000000.2310.8720.1060.0110.0110.4120.594001.1940000
Verkoop-, algemene en administratieve kosten 2.1175.9873.7012.7073.5253.6414.9843.264.66610.21918.9791.6871.9960.4731.6515.7944.264.4727.7533.10.3140.0320
Overige kosten 5.9950.202-0.004-0.001-00.0330.1532.5150.0113.338-5.8950.0031.2220.10404.0720000000.03
Bedrijfskosten 8.526.4554.3923.6233.8264.1016.9814.4426.07313.69518.9791.6871.9960.4822.1436.2684.6734.6067.8724.2081.7220.0320.03
Bedrijfsresultaat -8.52-6.455-4.392-3.623-3.826-4.101-6.981-4.442-6.073-13.695-18.979-1.684-1.949-0.388-2.109-6.042-3.749-3.607-7.335-4.163-1.721-0.032-0.03
Bedrijfsresultaat ratio 00000000000-138.517-29.285-3.082-8.021-9.251-3.151-3.084-13.658-48.196-722.13300
Totaal overige inkomsten en kosten netto -8.7170.2020.1530.072-00.0330.153-0.0020.0112.846-8.2550.2410.291-0.838-3.590.013-0.0660.006-1.6980.015000
Inkomen voor belasting -17.237-4.316-4.239-3.551-3.827-4.067-6.829-4.444-6.064-10.855-27.254-1.598-1.658-1.226-5.699-6.029-3.815-3.601-9.033-4.148000
Inkomen voor belasting ratio 00000000000-131.423-24.912-9.731-21.676-9.231-3.206-3.079-16.821-48.019000
Belastingkosten -6.52-1.937-0.1530.0030-0.033-0.153-0.004-0.0050.0050.020.154-0.051.0093.883-00.0430.0072.050.1141.7250.0320.03
Nettowinst -17.237-4.316-4.086-3.554-3.827-4.067-6.829-4.444-6.064-10.855-27.254-1.598-1.899-1.398-5.992-6.042-3.792-3.614-9.385-4.277-1.725-0.032-0.03
Nettowinstmarge 00000000000-131.423-28.536-11.093-22.789-9.25-3.187-3.09-17.476-49.516-723.75800
WPA (Winst Per Aandeel) -1.8-0.22-0.26-2.46-4.23-5.55-10.57-7.89-12.09-23.11-70.06-5.43-7.6-5.98-29.81-44.86-33.86-33.36-102.95-61.74-27.4-0.55-0.51
Verwaterde WPA -1.8-0.22-0.26-2.46-4.23-5.55-10.57-7.88-12.08-23.11-70.06-5.43-7.6-5.98-29.81-44.86-33.86-33.36-102.95-61.74-27.4-0.55-0.51
EBITDA -8.52-4.316-4.239-3.624-3.826-4.101-6.981-4.442-6.073-13.203-24.873-1.682-2.2160.491.596-6.026-3.677-3.612-5.636-4.155-1.721-0.032-0.03
EBITDA ratio 00000000000-138.304-33.2893.8896.071-9.227-3.09-3.088-10.495-48.103-722.13300